Financial Statements — SANG
Balance Sheet
(in millions USD)| Metric | FY
2025 | FY
2024 | FY
2023 | FY
2022 |
|---|
| Cash & Equivalents | 13.49 | 16.23 | 11.16 | 12.70 |
| Inventory | 8.23 | 14.77 | 17.97 | 17.43 |
| Total Current Assets | 42.62 | 57.11 | 61.62 | 61.01 |
| Goodwill | 186.84 | 187.50 | 187.50 | 210.01 |
| Total Non-current Assets* | 303.92 | 343.54 | 381.12 | 498.53 |
| Total Assets | 346.55 | 400.65 | 442.75 | -- |
| Total Current Liabilities | 49.48 | 60.10 | 63.19 | 78.41 |
| Total Non-current Liabilities* | 42.87 | 80.81 | 113.44 | 204.73 |
| Total Liabilities | 92.35 | 140.92 | 176.63 | -- |
| Retained Earnings | (146.94) | (141.93) | (133.28) | (104.25) |
| Total Stockholder Equity | 254.20 | 259.73 | 266.12 | 293.81 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | FY
2025 | FY
2024 | FY
2023 | FY
2022 |
|---|
| Total Revenue | 236.69 | 247.28 | 252.53 | 224.35 |
| Cost of Revenue* | 74.94 | 74.46 | 79.74 | 67.46 |
| Gross Profit | 161.75 | 172.82 | 172.79 | 156.89 |
| Research & Development | 42.15 | 39.54 | 37.47 | 34.16 |
| Selling, General & Admin | 37.13 | 43.19 | 76.36 | 75.20 |
| Total Operating Expenses | -- | -- | -- | 162.77 |
| Interest Expense | 4.01 | 6.64 | 6.77 | 3.86 |
| Pretax Income | (6.34) | (9.50) | (31.96) | (104.39) |
| Tax Provision | (1.33) | (0.84) | (2.93) | 6.39 |
| Net Income | (5.01) | (8.66) | (29.03) | (110.78) |
| Basic EPS | (0.15) | (0.26) | (0.88) | (3.52) |
| Diluted EPS | (0.15) | (0.26) | (0.88) | (3.52) |
* Derived from reported values
Cash Flow Statement
(in millions USD)| Metric | FY
2025 | FY
2024 | FY
2023 | FY
2022 |
|---|
| Operating Cash Flow | 41.79 | 44.25 | 26.49 | 21.06 |
| Investing Cash Flow | (8.84) | (10.91) | (11.27) | (55.82) |
| Financing Cash Flow | (35.68) | (28.26) | (16.77) | 25.37 |
